SignalHF vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Implicity
VS
by RhythmScience

AI Verdict

SignalHF is an FDA-cleared AI algorithm specifically designed to predict heart failure hospitalizations within 30 days by analyzing cardiac implantable electronic device data, enabling targeted early intervention. Rhythm360 offers a broader, integrated platform for comprehensive cardiac care, including heart failure management with predictive algorithms, alongside hypertension and rhythm management, and extensive operational features like EHR integration and automated billing. While both leverage AI for heart failure, SignalHF provides a specialized, FDA-cleared predictive capability, whereas Rhythm360 offers a more encompassing solution for overall cardiac care workflow and multiple conditions.

Choose SignalHF if…

Choose SignalHF if your primary focus is on leveraging AI for highly specific, proactive prediction of heart failure hospitalizations within 30 days, particularly for patients with cardiac implantable electronic devices (CIEDs). This tool is best suited for care teams aiming to utilize CIED data to enable early intervention and personalized care plans to prevent acute heart failure events.

View SignalHF →

Choose Rhythm360 if…

Choose Rhythm360 if your practice requires a comprehensive, vendor-neutral platform to unify and manage diverse cardiac monitoring data across various conditions like hypertension, heart failure, and arrhythmias. This solution is ideal for streamlining workflows, significantly reducing alert fatigue with AI-driven triage, and automating administrative tasks such as CPT code documentation and billing, potentially with integrated technician oversight.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature SignalHF Rhythm360
Pricing Contact for pricing Flexible pricing model that scales with clinic size and platform usage.
Deployment SaaS Cloud-based SaaS platform
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rhythm360

Tool B (Rhythm360) explicitly mentions a HIPAA-compliant mobile application for clinicians and extensive bi-directional EHR integration, which suggests a highly accessible and integrated user experience. Its focus on AI-driven alert triage also directly addresses a common pain point in clinical workflows by reducing alert fatigue.

Clinical Value

SignalHF

Tool A (SignalHF) features an FDA-cleared AI algorithm specifically designed to predict heart failure hospitalizations within 30 days, enabling early intervention. This specific regulatory clearance for a predictive outcome provides a strong, validated indicator of its clinical efficacy and value.

Pricing & Value

Tie

Tool B (Rhythm360) offers more transparency regarding its pricing model, stating it's flexible and scales with clinic size and usage, though it notes 'premium pricing.' Tool A (SignalHF) only states 'contact for pricing' with no further details. Without specific pricing figures for either tool, it is impossible to accurately compare their value propositions.

Enterprise Readiness

Rhythm360

Tool B (Rhythm360) demonstrates superior enterprise readiness through its comprehensive bi-directional EHR integrations with major systems like Epic, Cerner, and Athenahealth. Additionally, its automated CPT code documentation and billing features significantly streamline operational and financial processes for large healthcare organizations.

Innovation

Tie

Tool A (SignalHF) showcases innovation with its FDA-cleared AI algorithm for predicting heart failure hospitalizations from CIED data, a highly specific and impactful predictive capability. Tool B (Rhythm360) demonstrates innovation through its broad application of AI, including AI Data Normalization via computer vision for parsing diverse data formats like PDFs, and comprehensive AI-driven alert triage.

Support & Docs

Rhythm360

Tool B (Rhythm360) explicitly offers optional 24/7/365 oversight by certified cardiac technicians (CCTs), indicating a robust and comprehensive support structure. Tool A (SignalHF) provides no information regarding its support offerings or documentation in the provided facts.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature SignalHF Rhythm360
Product Name SignalHF Rhythm360
Company Implicity RhythmScience
Primary Use Case / Description Predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices, enabling early intervention. Unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue.
Device Compatibility Manufacturer-agnostic compatibility with various CIEDs (pacemakers, ICDs, CRTs) Vendor-neutral data aggregation (all major OEMs: Medtronic, Boston Scientific, Abbott, Biotronik)
Key AI Functionality FDA-cleared AI algorithm for heart failure prediction; Predicts heart failure hospitalizations within 30 days; AI-driven alert management. AI-driven alert triage (80% faster response times, reduces alert fatigue); AI Data Normalization; Heart Failure Management (predictive algorithms, GDMT optimization).

Videos

Demos, reviews, and walkthroughs featuring SignalHF and Rhythm360.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

SignalHF by Implicity is an FDA-cleared AI algorithm specifically designed to predict heart failure hospitalizations within 30 days by analyzing data from cardiac implantable electronic devices, enabling early intervention. Rhythm360 by RhythmScience is an AI-powered integrated platform that unifies cardiac monitoring data to provide actionable insights for hypertension, heart failure, and rhythm management.
SignalHF offers manufacturer-agnostic compatibility with various cardiac implantable electronic devices (CIEDs), including pacemakers, ICDs, and CRTs. Rhythm360 provides vendor-neutral data aggregation from all major OEM cardiac monitoring devices and offers bi-directional integration with major EHRs such as Epic, Cerner, Athenahealth, and eClinicalWorks.
SignalHF generates automatic alerts for care teams based on risk scores and utilizes AI-driven alert management to filter and highlight relevant events. Rhythm360 features AI-driven alert triage, which is stated to reduce alert fatigue and enable 80% faster response times.
SignalHF's description focuses on clinical prediction and alert management, without detailing administrative or billing workflow support. Rhythm360 offers automated CPT code documentation and billing for various codes, including 93298, 93299, 99454, 99453, and 99457.
SignalHF generates automatic alerts for care teams based on risk scores. Rhythm360 offers optional 24/7/365 oversight by certified cardiac technicians (CCTs) as part of its service.

Backers

Who funded each tool's parent company.

SignalHF

AI Tool Finder
AI-powered search. Results may not be comprehensive.